Navigation Links
New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry
Date:3/17/2008

s, with venous patency achieved in all cases. No adverse events were reported in the acute procedural follow-up period. Venous angioplasty, and/or stenting, were also used in the study in conjunction with the Trellis procedure to treat underlying problems depending on individual patient needs, such as a narrow area in the vein that would make a person susceptible to future clots.

About The Trellis(R)-8 Infusion System

The Trellis(R)-8 Infusion System is positioned at the site of the clot and a balloon is inflated on both sides of the clot to prevent pieces of the clot from traveling to other parts of the body and to isolate the treatment zone, so that there is less chance the infused drug will cause bleeding. Then a "dispersion wire" is fed through the catheter of the system. The wire begins to rotate, mixing the clot-busting drug within the clot; the clot pieces are aspirated into the catheter and removed from the body.

The Trellis is approved by the Food and Drug Administration (FDA) as a drug-infusion catheter for peripheral vascular clots. The drug and device have been used for years to remove blood clots from arteries and veins. The data are specific to DVT, showing that it works and is safe.

About the Society of Interventional Radiology

Interventional radiologists are physicians who specialize in minimally invasive, targeted treatments. They offer the most in-depth knowledge of the least invasive treatments available coupled with diagnostic and clinical experience across all specialties. They use X-ray, MRI and other imaging to advance a catheter in the body, usually in an artery, to treat at the source of the disease internally. As the inventors of angioplasty and the catheter-delivered stent, which were first used in the legs to treat peripheral arterial disease, interventional radiologists pioneered minimally invasive modern medicine.

Today many conditions that once required surgery can be treated less invas
'/>"/>

SOURCE Society of Interventional Radiology
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
2. Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome
3. Women Invited to Join New Health Registry to Advance Research
4. Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
5. American Heart Association Journal Report: Reducing Kids Salt Intake May Lower Soft Drink Consumption, Reducing Obesity, High Blood Pressure and Later Health Risks
6. Study Shows: New Blood Test Proven Six Times More Effective For Tuberculosis Control
7. Novel Small Molecule Therapy Shows Benefit for Anemic Patients Via Hydration of Red Blood Cells
8. AcroMetrix Renews Contract With Group Services for Americas Blood Centers
9. Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
10. BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures
11. Biocept Announces Study to Isolate Circulating Tumor Cells from Blood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)BETHESDA, Md., Dec. 4 Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") (OTC Bulletin Board: NWBO) announced today that the US Patent and Trademark Office has allowed its patent application o
(Date:12/3/2009)ACTON, Mass., Dec. 3 Allen Medical Systems, a subsidiary of Hill-Rom Holdings, Inc. (NYSE: HRC ), today announced the launch of its new Allen Amatech(TM) OEM (Original Equipment Manufacturer) busin
(Date:12/3/2009)DOYLESTOWN, Pa., Dec. 3 Ted Karkus, Chairman and CEO of The Quigley Corporation, (Nasdaq: QGLY ) www.quigleyco.com announced today that the Company has completed its evaluation of its opportunitie
Breaking Medicine Technology:Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3CDPHP Medicare Choices Expands Service Area Northward 59305 1CDPHP Medicare Choices Expands Service Area Northward 59305 2CDPHP Medicare Choices Expands Service Area Northward 59305 3Iowa Committee Makes Recommendations to Increase Value in Health Care 59300 1Iowa Committee Makes Recommendations to Increase Value in Health Care 59300 2Iowa Committee Makes Recommendations to Increase Value in Health Care 59300 3Iowa Committee Makes Recommendations to Increase Value in Health Care 59300 4Iowa Committee Makes Recommendations to Increase Value in Health Care 59300 5Regulatory Leader in OASIS Documentation Introduces OASIS C Products 5400 1Regulatory Leader in OASIS Documentation Introduces OASIS C Products 5400 2
...OME, Sept. 8 Novo Nordisk (NYSE: NVO ), a,global... clinical study,(LEAD(TM) 4) today at the 44th ann...udy of Diabetes that demonstrated adding the inves...log, to metformin and rosiglitazone in,the treatme...cose lowering,(HbA1c), weight loss, blood pressure...
...ILLMAN, Mich., Sept. 5 When Michigan,s first chro...ail deer at a deer farm in,Kent County, state and ...er,on the farmer,s property and began the process ... issuing the following statement on the negative C...t County Farm., The deer farm industry today rece...
Other Medicine Technology:Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes 2Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes 3Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes 4Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes 5Deer Farm Industry in Michigan Issues Statement on the Negative CWD Test Results at Kent County Deer Farm 2Deer Farm Industry in Michigan Issues Statement on the Negative CWD Test Results at Kent County Deer Farm 3
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)Case Western Reserve University researchers, from the School of Medicine,s Department of Nutrition, discovered two new metabolic pathways by which products of lipid peroxidation and some drugs of abus
Breaking Medicine News(10 mins):Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2
... Comprehensive Solution , , FALLS CHURCH, Va. and...ociation of periOperative Registered Nurses (AORN)... Standardized Perioperative Framework, software co...n a series of AORN offerings designed to improve p...
...y Corporation now Offering Allergy-certified Produ...Standards Ltd. (ASL), an Ireland-based, physician-...that Forbo Flooring Systems and Amway Corporation ...ng product line, while Amway Corporation received ...
... Biology and Regeneration Award is being presented...alifornia, San Francisco (UCSF), USA. The Internat...present the,award at its 87th General Session & Ex...ignificant contributions to,our understanding of t...
...n of methicillin-resistant Staphylococcus aureus ...ates during the past decadeinherits its destructiv...terium called USA500 rather than randomly acquirin...eases (NIAID), part of the National Institutes of ...
...h Plan, a network of federally qualified community...from the Economic Stimulus Package (the American R...nd specialty health care in Corona, Queens. , , ... government. The funding is important to all of us...
...(TM), the largest provider of non-clinical busines... practices worldwide, today announced that CEO and...pany,s Chairman of the Board. , , "Chris, leaders...PatientFYI. "Under Chris, leadership, OrthoSynetic...
Other Medicine News:Health News:CSC and AORN Bring Standardized Electronic Health Framework to Perioperative Nursing Care 2Health News:CSC and AORN Bring Standardized Electronic Health Framework to Perioperative Nursing Care 3Health News:Ireland's Allergy Standards Limited Adds Two New U.S. Names to Line-Up of Companies Making Allergy-Certified Consumer Products 2Health News:MRSA study suggests strategy shift needed to develop effective therapeutics 2Health News:Urban Health Plan Receives $1.3M from Economic Stimulus Package to Increase Health Care Access in Corona, Queens 2
... immunoassay (EIA) test kit is to be used for the ...n human serum during the second half of pregnancy.... immunoassay, which is based on the,principle of...s conjugated to the enzyme,horseradish peroxidas...
FSH EIA Reproductive Markers 025-BC-1029 Follicle Stimulating Hormone
...t androgen secreted into the blood. In males, test...ls of the testes; in females ca. 50% of circulatin...sion of androstenedione, ca. 25% from the ovary an...e ELISA KIT is based on the competition principle ...
Microalbumin Turbidimetric Lipid / Protein Quantification 021-SDX001
Medicine Products: